LionartMD vs Jin | 53–30 | 63.86% |
LionartMD vs Hwoarang | 51–29 | 63.75% |
LionartMD vs Steve | 53–25–1 | 67.95% |
LionartMD vs Bryan | 42–25 | 62.69% |
LionartMD vs Law | 49–15 | 76.56% |
LionartMD vs Lee | 36–24 | 60.00% |
LionartMD vs Xiaoyu | 27–24 | 52.94% |
LionartMD vs Kazuya | 37–14 | 72.55% |
LionartMD vs Reina | 26–25 | 50.98% |
LionartMD vs Heihachi | 35–16 | 68.63% |
LionartMD vs Paul | 37–12 | 75.51% |
LionartMD vs Lili | 31–18 | 63.27% |
LionartMD vs Victor | 28–19 | 59.57% |
LionartMD vs King | 29–17 | 63.04% |
LionartMD vs Raven | 29–14 | 67.44% |
LionartMD vs Yoshimitsu | 27–14 | 65.85% |
LionartMD vs Devil Jin | 29–12 | 70.73% |
LionartMD vs Lars | 22–17 | 56.41% |
LionartMD vs Azucena | 20–19 | 51.28% |
LionartMD vs Jun | 24–14 | 63.16% |
LionartMD vs Leo | 19–18 | 51.35% |
LionartMD vs Leroy | 28–7 | 80.00% |
LionartMD vs Feng | 25–9 | 73.53% |
LionartMD vs Alisa | 17–16 | 51.52% |
LionartMD vs Asuka | 20–12 | 62.50% |
LionartMD vs Dragunov | 21–11 | 65.62% |
LionartMD vs Nina | 23–7 | 76.67% |
LionartMD vs Claudio | 12–16 | 42.86% |
LionartMD vs Clive | 19–9 | 67.86% |
LionartMD vs Zafina | 16–11 | 59.26% |
LionartMD vs Shaheen | 13–11 | 54.17% |
LionartMD vs Eddy | 14–8 | 63.64% |
LionartMD vs Jack-8 | 14–4 | 77.78% |
LionartMD vs Kuma | 14–4 | 77.78% |
LionartMD vs Lidia | 3–7 | 30.00% |
LionartMD vs Panda | 2–2 | 50.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.